XRTX · XORTX Therapeutics Inc
United States · RS rating 6 · As of 2026-11-03
| Price | 1.00 USD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 6 / 7 / 14 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 4 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -81.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +69.2% |
| Market cap (USD) | $4.3M |